The slip
PARKINSON RECEIPTno. 13433
28 Oct 2026, 22:05 UTCdopamine neurons, braak
predictionBRK1 in dopamine neurons tracks Braak Lewy-body stage
registeredd22d6bda1e2b6d30
discovery+0.44 p=0.237 n=9
replication-0.11 p=0.787 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.44, p 0.237)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT938097f6876edc05010ddfca…
follows e874115351e7…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 13433: BRK1 in dopamine neurons, braak
- power
- full sample +0.12 (p 0.633, n 18), 95% CI -0.37 to +0.56. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.11 (p 0.664, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.09 (p 0.735, n 18). could be the mix.
- skeptic
- leave-one-out range +0.01 to +0.25, sign flips 0; without severely affected donors +0.12 (p 0.633, n 18). fragile.
- cell type
- strongest in astrocytes: -0.76 (p 2.5e-4, n 18) vs +0.12 in dopamine neurons. proposing astrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for BRK1 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up BRK1 · astrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.13 p 0.657 (needs p < 1.7e-4)